Mike. joining today. you, And morning, Thank Good us everyone. thank you for
Board not I I determine to to The call. is that like its further review we alternatives a progressing company’s Before Board the comments Directors announced strategic have the of initiated today’s would on as shareholder on maximize August and begin, XXXX, we to review, any path or XX, best of through updates remind will value. everyone
particular assurance in process be any result As no a transaction outcome. will that can strategic strategic reminder, the there a other alternative or
a making few from customer engagement. with we review highlights quarter, will to of a the begin respect with third are the discussion my by I progress followed
details Sean will and Next, execution. provide And actions I of taken improve fourth will are quarter being discuss we performance to and third our finally, making quarter the commercial outlook. enhancements
assuming team. been improving placements. commercial experience customer our and sales the of My leadership responsibility focus As remains has priority and effectiveness Growth efficiency engagement accelerating our System an organization, enhancing top on since Direct and
in ahead million. in most Systems in August. which We are was We of customer were expected we third our therapy with cadence Direct $X.X we therapies. the pleased revenue other the with one areas and QX placed focused our commercial a when guidance the was Total two U.S.-based X customer quarter, performance updated field European biopharma placed Growth quarter the on a to during systems system mRNA in gene went in
new As and $XX Europe pipeline commercial traveled building of In-person meet with clear a in improve and year with quarter, are it commercial about and our for and customers. prospective are our existing customer is my result million. to existing access revenue at continues of to we to was sites teams full excited our I customers to XXXX. personally XXXX I’m performance, both Across QX reaffirming visits, Asia proposition resonating, and connecting our that the sales value guidance least the
We number have time of in-person conferences first the years. also industry in for a X over in participated
participate Joint of future. was Microbiology is a facility. Regulatory of thinks number and We about at events shaping XXst around year, the hosting increasing a in Lab In XX in on are presentation the Washington, to PDA/FDA over track sessions Lowell of at and of and Direct September, Growth and tours to Munich in the this the topic I Century. on in invited been customer Micro our and conferences attend hands-on an facility the the Rapid we on Conference how have lab U.S. I our globe gave D.C. calendar Europe
the micro The a a covering Growth insights the encouraged can technologies deliver market the with and and industry regulatory X.X colleague, new strongly landscape Century. great took the into micro included such how as into automation, in lab adopting of lab part and participants Growth required QC to technologies that the discussion safety QC panel consider data provided speed the modernize Micro Direct also panel micro senior such and Rapid future who move Along XXst as regulator QC the Direct. and integrity, I patient a
a an and we It exchange the the Additionally, as from the benefits and Micro cost, such session. interacted attendance Growth Direct and technology efficiency, patient regulators, PDA companies the for pharma Also, year, pharmaceutical among the the events this of microbiology Sponsor of and was representatives we inspiring the global during is important to discussed Pharmaceutical largest panel that bring conferences of October, as Platinum Historically, industry, of were one Microbiology early one the is Q&A and Micro. Rapid Conference. most of annual benefits in XXXX were safety manufacturing. with the Rapid in
received System was full by we display talks several attended is PDA, professionals, thought authorities. conference and hosted and Growth regulatory control automated tech we significant. poster the customer and This leadership at presentations. The on global an academia and industry featured Direct quality operational RMB’s year was in attention
executive at dinner engagement was event that several between by teams and dozen customers. a key commercial executives customers. This Importantly, hosted Micro attended users leadership special prospective decision-makers existing Rapid and and and our enabled deep
manufacturing. better we to in-person visited our present Conference customers, and cases and onset the a have environment we Growth us discussing in Being gain facilities workflows regulatory our Growth provide our demonstrate on-site can in fully also been and to to of of when meetings of the meet the pharmaceutical operations. and at facilities, sales COVID, are In have integrity the manufacturing we state-of-the-art, demands of hands-on educate, showcase the in-person Growth where capabilities, in-person future As how and highly consumables better of Direct automated capabilities Direct Direct QC their challenges a process. with data process demonstrations our System. customers the since been The is show and we able understanding allows demonstrations manufacturing our the PDA competitive, speed, of the micro case have
As we improving access quarter, element sales. discussed one is driving last system customer of
brand enhance is of prospecting and The build our global of a generation life and of increasing we capabilities lead and marketing, for awareness priority top Our sales marketing team. expanded building and are capabilities by leads generation the effectiveness significantly is In sciences who on is director team our multinational global other the we by to continued number in consistency capabilities quality infield August, hiring our to experienced marketing lead increased of combination generating. companies. sales
portion also accounts. implementing our A Growth meaningful global tasked manufacturing from in global funnel expand team our We to commercial have key targeted across our customers includes strategies opportunities looking Direct new in existing leadership multi-system of networks. at rollouts
exciting of and customers. large also new, We developing midsized number are a with opportunities
papers thought our sales leader the forward, Looking publish increasing of white market. an science-based as that number the and leads webinars technical of will Micro efforts to and produce generate expect in expand are we new awareness solutions. innovative Rapid position to These to continue expected and
development provide update an to I product our on would Now, efforts. gears shift and like
and are We customer PDA Conference recent detection mold there of announce high innovative our product excitement. a during to level where the interest was extremely pleased
Alarm alerts generates a differentiate It of early pharmaceutical Mold manufacturing capability available be the Mold in automated Direct X contamination. for from We software and molds in accurately intervention, other detected as and Growth are update. this and incorporates soon data process. a product, further reduced as and This mitigation designed mold risk will officially RMBNucleus System detect Alarm, little enhanced day. branding as as on the allows is and integrity to rapidly through new it organisms environmental is
Turning to partner rapid customer our sterility, our is beta ongoing. process with
significantly value the of take on Direct our customers sterility test the to results. before the confirming time accelerate and enabled can the We speed often Sterility We detection core a testing product is final XX valuable complete are addressing accuracy and will and more release product to about days and and results. gaining using or feedback traditional that method. Growth excited final rapid to and offering are
updates through We move process. as to continue will the we provide beta
customer differentiation we commercial introduction Growth that to have the We execution with high customers. with pleased continue future our provide actions importantly, and more improve the sales our in we And take expanding product cost taken we Growth we’ll improve platform. remains wrap appropriate Mold and provides to commercial Alarm Direct of to confident To in system up, progress quarters. and that our are right have Interest strengthen and in making the strategy and to engagement, value Direct we continue can even we to flexibility we are advance invest actions right-size to remain advance the structure as place, bring us our in development. execution
outlook. prepared the more detail third concludes and to some in around quarter to our quarter fourth our I remarks. turn my That performance will discuss call Sean now comments Sean? provide over